Annual EBITDA:
-$13.99M+$9.74M(+41.04%)Summary
- As of today, XERS annual EBITDA is -$13.99 million, with the most recent change of +$9.74 million (+41.04%) on December 31, 2024.
- During the last 3 years, XERS annual EBITDA has risen by +$99.67 million (+87.69%).
- XERS annual EBITDA is now -6.90% below its all-time high of -$13.09 million, reached on December 31, 2016.
Performance
XERS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$8.59M+$7.37M(+599.84%)Summary
- As of today, XERS quarterly EBITDA is $8.59 million, with the most recent change of +$7.37 million (+599.84%) on June 30, 2025.
- Over the past year, XERS quarterly EBITDA has increased by +$11.73 million (+373.87%).
- XERS quarterly EBITDA is now at all-time high.
Performance
XERS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$7.39M+$11.73M(+270.38%)Summary
- As of today, XERS TTM EBITDA is $7.39 million, with the most recent change of +$11.73 million (+270.38%) on June 30, 2025.
- Over the past year, XERS TTM EBITDA has increased by +$24.63 million (+142.89%).
- XERS TTM EBITDA is now at all-time high.
Performance
XERS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
XERS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +41.0% | +373.9% | +142.9% |
| 3Y3 Years | +87.7% | +142.9% | +106.2% |
| 5Y5 Years | +88.1% | +139.7% | +107.9% |
XERS EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +87.7% | at high | +156.9% | at high | +106.7% |
| 5Y | 5-Year | at high | +88.1% | at high | +117.9% | at high | +105.9% |
| All-Time | All-Time | -6.9% | +88.1% | at high | +117.9% | at high | +105.9% |
XERS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $8.59M(+599.8%) | $7.39M(+270.4%) |
| Mar 2025 | - | $1.23M(-78.5%) | -$4.34M(+69.0%) |
| Dec 2024 | -$13.99M(+41.0%) | $5.72M(+170.2%) | -$13.99M(+39.3%) |
| Sep 2024 | - | -$8.15M(-159.8%) | -$23.07M(-33.8%) |
| Jun 2024 | - | -$3.14M(+62.8%) | -$17.24M(+30.3%) |
| Mar 2024 | - | -$8.43M(-151.6%) | -$24.73M(-4.2%) |
| Dec 2023 | -$23.73M(+65.8%) | -$3.35M(-44.2%) | -$23.73M(+7.9%) |
| Sep 2023 | - | -$2.32M(+78.1%) | -$25.78M(+33.2%) |
| Jun 2023 | - | -$10.63M(-42.9%) | -$38.57M(+19.6%) |
| Mar 2023 | - | -$7.44M(-37.8%) | -$47.96M(+29.6%) |
| Dec 2022 | -$69.31M(+39.0%) | -$5.40M(+64.3%) | -$68.09M(+38.5%) |
| Sep 2022 | - | -$15.11M(+24.5%) | -$110.79M(+7.3%) |
| Jun 2022 | - | -$20.01M(+27.4%) | -$119.57M(+4.3%) |
| Mar 2022 | - | -$27.57M(+42.7%) | -$124.95M(-9.9%) |
| Dec 2021 | -$113.67M | -$48.09M(-101.3%) | -$113.67M(-38.0%) |
| Sep 2021 | - | -$23.89M(+6.0%) | -$82.39M(-14.8%) |
| Jun 2021 | - | -$25.40M(-56.0%) | -$71.79M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.28M(+3.2%) | -$68.04M(+14.0%) |
| Dec 2020 | -$79.12M(+32.8%) | -$16.82M(-26.6%) | -$79.12M(+15.8%) |
| Sep 2020 | - | -$13.29M(+38.6%) | -$93.93M(+14.3%) |
| Jun 2020 | - | -$21.65M(+20.9%) | -$109.63M(+9.5%) |
| Mar 2020 | - | -$27.36M(+13.5%) | -$121.08M(-2.8%) |
| Dec 2019 | -$117.80M(-105.9%) | -$31.63M(-9.1%) | -$117.80M(-11.8%) |
| Sep 2019 | - | -$28.99M(+12.4%) | -$105.36M(-16.6%) |
| Jun 2019 | - | -$33.10M(-37.5%) | -$90.39M(-29.8%) |
| Mar 2019 | - | -$24.08M(-25.5%) | -$69.64M(-21.7%) |
| Dec 2018 | -$57.22M(-117.3%) | -$19.19M(-36.8%) | -$57.22M(-21.6%) |
| Sep 2018 | - | -$14.03M(-13.6%) | -$47.07M(-16.2%) |
| Jun 2018 | - | -$12.35M(-6.0%) | -$40.52M(-43.8%) |
| Mar 2018 | - | -$11.65M(-28.9%) | -$28.17M(-33.3%) |
| Dec 2017 | -$26.33M(-101.1%) | -$9.04M(-21.0%) | -$21.13M(-74.8%) |
| Sep 2017 | - | -$7.47M(-62.1%) | -$12.09M(-162.1%) |
| Mar 2017 | - | -$4.61M | -$4.61M |
| Dec 2016 | -$13.09M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual EBITDA year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly EBITDA year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM EBITDA year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual EBITDA?
The current annual EBITDA of XERS is -$13.99M
What is the all-time high annual EBITDA for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual EBITDA is -$13.09M
What is Xeris Biopharma Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, XERS annual EBITDA has changed by +$9.74M (+41.04%)
What is Xeris Biopharma Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of XERS is $8.59M
What is the all-time high quarterly EBITDA for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly EBITDA is $8.59M
What is Xeris Biopharma Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, XERS quarterly EBITDA has changed by +$11.73M (+373.87%)
What is Xeris Biopharma Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of XERS is $7.39M
What is the all-time high TTM EBITDA for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM EBITDA is $7.39M
What is Xeris Biopharma Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, XERS TTM EBITDA has changed by +$24.63M (+142.89%)